NCT04161911View on ClinicalTrials.gov

A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy

CompletedOBSERVATIONAL
Enrollment

1,426

Participants

Timeline

Start Date

October 29, 2018

Primary Completion Date

November 15, 2018

Study Completion Date

November 19, 2018

Conditions
Hepatocellular Carcinoma
Trial Locations (1)

08543

Bristol Myers Squibb, CORDS Research, Princeton

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY